Wird geladen...
Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine—A Randomized Phase II Trial
This study is an investigator-initiated randomized phase II trial focusing on the treatment of advanced biliary tract cancer with either oxaliplatin 50 mg/m(2) and gemcitabine 1000 mg/m(2) on day 1 in a two-week cycle with capecitabine 650 mg/m(2) twice-daily continuously or cisplatin 25 mg/m(2) and...
Gespeichert in:
| Veröffentlicht in: | Cancers (Basel) |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7409144/ https://ncbi.nlm.nih.gov/pubmed/32698410 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12071975 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|